Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 22, 2013 08:00 ET | Source: Acasti Pharma Inc.

Acasti Announces Fiscal 2013 Results and Provides Update on Status of Clinical Trials

LAVAL, Quebec, May 22, 2013 (GLOBE NEWSWIRE) -- Acasti Pharma ("Acasti" or the "Corporation") (Nasdaq:ACST) (TSX-V:APO), a Neptune Technologies & Bioressources Inc.'s ("Neptune") subsidiary,...
March 19, 2013 08:00 ET | Source: Acasti Pharma Inc.

Acasti Pharma Presents Preliminary Data Moving Forward With Clinical Strategy

LAVAL, Quebec, March 19, 2013 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. ("Acasti") (TSX-V:APO) (Nasdaq:ACST), a Neptune Technologies & Bioressources Inc. ("Neptune") subsidiary, announces encouraging...
January 15, 2013 08:00 ET | Source: Acasti Pharma Inc.

Acasti Pharma Reports Its Third Quarter Results

LAVAL, Quebec, Jan. 15, 2013 (GLOBE NEWSWIRE) -- Acasti Pharma ("Acasti" or the "Corporation") (Nasdaq:ACST) (TSX.V:APO), a Neptune Technologies & Bioressources Inc. ("Neptune") subsidiary,...
January 07, 2013 08:00 ET | Source: Acasti Pharma Inc.

Acasti Pharma Shares to Trade on NASDAQ

LAVAL, Quebec, Jan. 7, 2013 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. ("Acasti") (Nasdaq:ACST) (TSX-V:APO), a Neptune Technologies & Bioressources Inc. ("Neptune") subsidiary, is pleased to announce...
December 17, 2012 08:00 ET | Source: Acasti Pharma Inc.

Acasti Pharma Provides an Insight of Its Current Clinical Trials Results

LAVAL, Quebec, Dec. 17, 2012 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. ("Acasti") (TSX-V:APO), a Neptune Technologies & Bioressources Inc. ("Neptune") subsidiary, announces a clinical study update...
December 04, 2012 09:25 ET | Source: Acasti Pharma Inc.

Acasti Pharma Becomes Royalty Free

LAVAL, Quebec, Dec. 4, 2012 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. ("Acasti") (TSX.V:APO) announces it has entered into a prepayment agreement (the "Prepayment Agreement") with Neptune Technologies...
November 12, 2012 13:49 ET | Source: Acasti Pharma Inc.

Acasti Pharma Provides Update After Explosion at Neptune's Plant

LAVAL, Quebec, Nov. 12, 2012 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. ("Acasti") (TSX-V:APO), a Neptune Technologies & Bioressources Inc. ("Neptune") subsidiary, regrets to report that in the...
October 17, 2012 08:00 ET | Source: Acasti Pharma Inc.

Acasti Pharma Reports Its Second Quarter Results

LAVAL, Quebec, Oct. 17, 2012 (GLOBE NEWSWIRE) -- Acasti Pharma ("Acasti" or the "Corporation") (TSX.V.APO), a Neptune Technologies & Bioressources Inc. ("Neptune") subsidiary, reports the...
July 31, 2012 08:00 ET | Source: Acasti Pharma Inc.

Acasti Pharma First Quarter Results

LAVAL, Quebec, July 31, 2012 (GLOBE NEWSWIRE) -- Acasti Pharma ("Acasti" or the "Corporation") (TSX.V.APO), a Neptune Technologies & Bioressources Inc's ("Neptune") subsidiary, reports the...
July 09, 2012 09:00 ET | Source: Acasti Pharma Inc.

Acasti Pharma to Present at JMP Securities Healthcare Conference

LAVAL, Quebec, July 9, 2012 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. ("Acasti") (TSX-V:APO), a Neptune Technologies & Bioressources Inc. ("Neptune") subsidiary, announces it will present at the 2012...